Charmacy Pharmaceutical Co., Ltd. (HKG:2289)
7.31
+1.41 (23.90%)
Jan 2, 2026, 6:10 PM HKT
Charmacy Pharmaceutical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 48.28 | 53.28 | 51.34 | 90.47 | 23.15 | 40.56 | Upgrade |
Depreciation & Amortization | 29.34 | 29.75 | 26.47 | 30.68 | 32.03 | 24.55 | Upgrade |
Other Amortization | 7.66 | 6.27 | 2.95 | 2.89 | 1.73 | 0.81 | Upgrade |
Loss (Gain) From Sale of Assets | 0.08 | -0.31 | -0.05 | -65.84 | -0.15 | -0.02 | Upgrade |
Asset Writedown & Restructuring Costs | 0.2 | 0.36 | -0.01 | - | 0.01 | - | Upgrade |
Loss (Gain) From Sale of Investments | - | - | 0.1 | - | -0 | - | Upgrade |
Provision & Write-off of Bad Debts | -0.5 | 0.07 | 0.8 | 2.48 | -0.29 | 11.37 | Upgrade |
Other Operating Activities | 38.15 | 38.14 | 41.16 | 36.31 | 41.71 | 36.17 | Upgrade |
Change in Accounts Receivable | 2,647 | -409.63 | -98.17 | -222.47 | -54.81 | -158.03 | Upgrade |
Change in Inventory | 67.21 | 116.04 | -193.35 | -77.74 | 75.75 | -69.82 | Upgrade |
Change in Accounts Payable | -2,580 | 272.54 | 72.25 | 245.77 | -139.9 | 248.47 | Upgrade |
Operating Cash Flow | 256.1 | 106.04 | -96.54 | 44.05 | -19.54 | 131.08 | Upgrade |
Operating Cash Flow Growth | - | - | - | - | - | 3161.49% | Upgrade |
Capital Expenditures | -9.31 | -15.73 | -40.85 | -8.59 | -25.04 | -51.98 | Upgrade |
Sale of Property, Plant & Equipment | 0.05 | 0.08 | 80.19 | 80.35 | 0.64 | 0.06 | Upgrade |
Cash Acquisitions | - | - | - | - | - | -2.86 | Upgrade |
Other Investing Activities | - | - | - | - | 0 | - | Upgrade |
Investing Cash Flow | -9.26 | -15.64 | 39.34 | 71.76 | -24.4 | -54.78 | Upgrade |
Short-Term Debt Issued | - | 3,688 | 2,492 | 2,852 | 1,807 | 1,561 | Upgrade |
Long-Term Debt Issued | - | 1,266 | 836.6 | 2.26 | 974.03 | 957.63 | Upgrade |
Total Debt Issued | 5,185 | 4,955 | 3,329 | 2,855 | 2,781 | 2,518 | Upgrade |
Short-Term Debt Repaid | - | -3,883 | -2,388 | -3,017 | -1,830 | -1,576 | Upgrade |
Long-Term Debt Repaid | - | -1,038 | -767.41 | -3.58 | -824.11 | -888.63 | Upgrade |
Total Debt Repaid | -5,082 | -4,921 | -3,156 | -3,021 | -2,654 | -2,465 | Upgrade |
Net Debt Issued (Repaid) | 102.13 | 33.98 | 172.72 | -166.48 | 126.33 | 53.65 | Upgrade |
Common Dividends Paid | -65.58 | -64.2 | -75.5 | -28.44 | -52.49 | -56.51 | Upgrade |
Other Financing Activities | -201.72 | -1.31 | 4.04 | 3.71 | 0.56 | 0.18 | Upgrade |
Financing Cash Flow | -165.18 | -31.54 | 101.26 | -191.21 | 74.4 | -2.68 | Upgrade |
Foreign Exchange Rate Adjustments | -0 | 0.01 | 0.01 | 0.03 | - | 0 | Upgrade |
Net Cash Flow | 81.66 | 58.87 | 44.07 | -75.37 | 30.46 | 73.62 | Upgrade |
Free Cash Flow | 246.78 | 90.31 | -137.39 | 35.46 | -44.58 | 79.1 | Upgrade |
Free Cash Flow Margin | 5.82% | 2.04% | -3.12% | 0.85% | -1.18% | 1.98% | Upgrade |
Free Cash Flow Per Share | 2.29 | 0.84 | -1.27 | 0.33 | -0.41 | 0.73 | Upgrade |
Cash Income Tax Paid | 49.82 | 52.98 | 58.86 | 36.02 | 37.42 | 26.93 | Upgrade |
Levered Free Cash Flow | -56.44 | -69.75 | 10.27 | -145.91 | -28.06 | -12.53 | Upgrade |
Unlevered Free Cash Flow | -18.68 | -30.71 | 36.48 | -123.99 | -2.12 | 7.31 | Upgrade |
Change in Working Capital | 132.88 | -21.53 | -219.31 | -52.94 | -117.74 | 17.64 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.